RecruitingNCT06327516
Lysophosphatidylglycerol in Asthma Pathogenesis
Sponsor
Peking University Third Hospital
Enrollment
250 participants
Start Date
Jan 1, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to investigate the relationship between the small molecule metabolite lysophosphatidylglycerol and asthma clinical features and explore its involvement in asthma pathogenesis.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This study investigates the role of a molecule called lysophosphatidylglycerol (LPG) in asthma — a chronic lung condition causing wheezing, shortness of breath, and coughing. Researchers believe this naturally occurring lipid (fat molecule) may play a role in the inflammation underlying asthma and hope to better understand how it contributes to the disease.
**You may be eligible if...**
- You have been clinically diagnosed with asthma
**You may NOT be eligible if...**
- You also have COPD, bronchiectasis, pneumonia, obstructive sleep apnea, or a malignant tumor
- You have acute or chronic respiratory failure
- You have severe heart disease
- You are pregnant
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06327516
Related Trials
NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
NCT023278971 location
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
NCT05692180116 locations
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
NCT0556246662 locations
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581132 locations
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619156 locations